National Center for Medical Devices Reporting ( NCMDR ) A systematic database to manage medical devices' post-market activities, such as Medical devices reporting of Adverse events and complaints, as well as publishing the Safety alerts of Medical devices with follow-up implementation of the corrective actions to ensure the safety, efficacy and performance of medical devices.

An electronic system that used by the authorized organizations and companies which are dealing with controlled drugs and psychotropic substances. This system links between beneficiaries and the Saudi Food and Drug Authority (SFDA). So, SFDA can control and track controlled drugs and psychotropic substances electronically.

It provides many services for the stakeholders, obtaining standards, giving feedback on draft standards, proposing standards, and reviewing draft of standards before publishing

The leading regional regularity authority for food, drugs and medical devices with proffessional and excellent services that contributes to the protection and advancement of the health in Saudi Arabia

SFDA established Product Classification System for companies to classify their products and get to know the eligibility of products and whether it is subject to registration. The classification exclusively based on the SFDA criteria and products classification guidance. It is an optional service for companies and does not replace registration for other SFDA electronic systems

The Pharmacovigilance Electronic Reporting Service is an online spontaneous reporting system for adverse events and pharmaceutical products defects to facilitate the reporting for health care professionals and the public.​

An electronic system which aims to build-up a national database for all drug establishments including local and international companies and manufacturers, agents and wholesale distributors in Saudi Arabia.

An electronic system that enables users to issue a bill to get SFDA service

RSD is an electronic system that aims to insure drug safety by tracking all drugs in the supply chain from manufacturing till it reaches the consumer.